Contraception
News
Hormonal Contraceptives Insignificantly Lower Vitamin B12 Levels
Major Finding: During the first 6 months after the women started hormonal contraception, B12 levels declined by 97 pg/mL (20%) in the OC group and...
News
FDA: OCs Containing Drospirenone May Increase Blood Clot Risk
News for Your Practice
Drospirenone-containing birth control pills may increase risk of blood clots
Clinical Review
How to choose a contraceptive for your postpartum patient
An earlier follow-up visit is the first requisite. Also consider how soon your patient plans to resume intercourse, her risk of venous...
News
FDA Panel: Ortho Evra Benefits Outweigh Risks
News
FDA Panel Reviews VTE Risk for Some OCs
Clinical Review
How to prepare your patient for the many nuances of postpartum sexuality
Up-to-date strategies for educating and advising your patient are more effective (and efficient) than traditional counseling
News
Newer Progestogens: Study Confirms VTE Risk
Major Finding: The relative risk of confirmed VTE in users of OCs containing 30-40 mcg of ethinyl estradiol with levonorgestrel was 2.9,...
From the Editor
Not all contraceptives are suitable immediately postpartum
The prenatal period is the time to counsel your patient about risks advantages of post-delivery contraceptives—and encourage her to choose one
Expert Commentary
Remove the black-box warning for depot medroxyprogesterone acetate!
Guidance about DMPA in the black box isn’t evidence-based, and the warning deprives women of long-term use of this safe and effective...
Clinical Review
UPDATE ON CONTRACEPTION
When it comes to the morning-after pill, physicians need a wake-up call